pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents.

Classification kind code

Mark Details

Serial Number

1825825

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 12^th Oct 2018	Allowed
Submitted for opposition 51 on 12^th Oct 2018	Allowance Notice Sent
Submitted for opposition 42 on 27^th Jun 2018	Advertised
Submitted for opposition 26 on 07^th Jun 2018	Approved
Submitted for opposition 27 on 17^th Apr 2018	Approval Notice Sent
Submitted for opposition 22 on 08^th Jan 2018	Search Recorded
Submitted for opposition 20 on 08^th Jan 2018	Examiner's First Report
Submitted for opposition 31 on 10^th Mar 2017	Formalized
Submitted for opposition 1 on 07^th Mar 2017	Created
Submitted for opposition 30 on 06^th Mar 2017	Filed